Sejong Medical Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Byungsung Kim
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.4yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | no data |
Recent management updates
No updates
Recent updates
Sejong Medical (KOSDAQ:258830) Might Be Having Difficulty Using Its Capital Effectively
Mar 24
Update: Sejong Medical (KOSDAQ:258830) Stock Gained 53% In The Last Year
Mar 02Does The Market Have A Low Tolerance For Sejong Medical Co., Ltd.'s (KOSDAQ:258830) Mixed Fundamentals?
Feb 11We're Not Counting On Sejong Medical (KOSDAQ:258830) To Sustain Its Statutory Profitability
Jan 27Is Sejong Medical Co., Ltd. (KOSDAQ:258830) A Smart Choice For Dividend Investors?
Jan 12Income Investors Should Know That Sejong Medical Co., Ltd. (KOSDAQ:258830) Goes Ex-Dividend Soon
Dec 25Should We Be Excited About The Trends Of Returns At Sejong Medical (KOSDAQ:258830)?
Dec 23
These 4 Measures Indicate That Sejong Medical (KOSDAQ:258830) Is Using Debt Reasonably Well
Dec 08The Sejong Medical (KOSDAQ:258830) Share Price Has Gained 42% And Shareholders Are Hoping For More
Nov 19CEO
Byungsung Kim (54 yo)
1.4yrs
Tenure
Byungsung Kim serves as Chief Executive Officer at Sejong Medical Co., Ltd. since 2023. Byungsung Kim served as Representative Director at Sejong Medical Co., Ltd.